Nuveen Asset Management
PLX icon

Nuveen Asset Management’s Protalix BioTherapeutics PLX Stock Holding History

Nuveen Asset Management’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-271,795
Closed -$342K – 3397
2024
Q1 		$342K Hold
271,795
– – ﹤0.01% 3074
2023
Q4 		$484K Buy
271,795
+9,714
+4% +$17.3K ﹤0.01% 3013
2023
Q3 		$435K Hold
262,081
– – ﹤0.01% 2890
2023
Q2 		$524K Buy
+262,081
New +$524K ﹤0.01% 2897